A randomized, double-blinded, placebo-controlled, phase I/II, dose-ranging study of the safety, reactogenicity, and immunogenicity of intramuscular inactivated influenza A/H5N1 vaccine [influenza A virus vaccine-H5N1] in healthy adults

Trial Profile

A randomized, double-blinded, placebo-controlled, phase I/II, dose-ranging study of the safety, reactogenicity, and immunogenicity of intramuscular inactivated influenza A/H5N1 vaccine [influenza A virus vaccine-H5N1] in healthy adults

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Aug 2013

At a glance

  • Drugs Influenza A virus vaccine-H5N1 (Primary)
  • Indications Influenza A virus H5N1 subtype; Influenza A virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 13 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top